Literature DB >> 23740936

Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis.

Tomohiko Ishihara1, Yuko Ariizumi, Atsushi Shiga, Taisuke Kato, Chun-Feng Tan, Tatsuya Sato, Yukari Miki, Mariko Yokoo, Takeshi Fujino, Akihide Koyama, Akio Yokoseki, Masatoyo Nishizawa, Akiyoshi Kakita, Hitoshi Takahashi, Osamu Onodera.   

Abstract

Disappearance of TAR-DNA-binding protein 43 kDa (TDP-43) from the nucleus contributes to the pathogenesis of amyotrophic lateral sclerosis (ALS), but the nuclear function of TDP-43 is not yet fully understood. TDP-43 associates with nuclear bodies including Gemini of coiled bodies (GEMs). GEMs contribute to the biogenesis of uridine-rich small nuclear RNA (U snRNA), a component of splicing machinery. The number of GEMs and a subset of U snRNAs decrease in spinal muscular atrophy, a lower motor neuron disease, suggesting that alteration of U snRNAs may also underlie the molecular pathogenesis of ALS. Here, we investigated the number of GEMs and U11/12-type small nuclear ribonucleoproteins (snRNP) by immunohistochemistry and the level of U snRNAs using real-time quantitative RT-PCR in ALS tissues. GEMs decreased in both TDP-43-depleted HeLa cells and spinal motor neurons in ALS patients. Levels of several U snRNAs decreased in TDP-43-depleted SH-SY5Y and U87-MG cells. The level of U12 snRNA was decreased in tissues affected by ALS (spinal cord, motor cortex and thalamus) but not in tissues unaffected by ALS (cerebellum, kidney and muscle). Immunohistochemical analysis revealed the decrease in U11/12-type snRNP in spinal motor neurons of ALS patients. These findings suggest that loss of TDP-43 function decreases the number of GEMs, which is followed by a disturbance of pre-mRNA splicing by the U11/U12 spliceosome in tissues affected by ALS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740936     DOI: 10.1093/hmg/ddt262

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  32 in total

Review 1.  The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.

Authors:  Elisabeth Daguenet; Gwendal Dujardin; Juan Valcárcel
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

Review 2.  Developing therapies for spinal muscular atrophy.

Authors:  Mary H Wertz; Mustafa Sahin
Journal:  Ann N Y Acad Sci       Date:  2015-07-14       Impact factor: 5.691

Review 3.  Cajal bodies in neurons.

Authors:  Miguel Lafarga; Olga Tapia; Ana M Romero; Maria T Berciano
Journal:  RNA Biol       Date:  2016-09-14       Impact factor: 4.652

Review 4.  Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis.

Authors:  Sami J Barmada
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

5.  Nuclear localization of SMN and FUS is not altered in fibroblasts from patients with sporadic ALS.

Authors:  Shingo Kariya; Jacinda B Sampson; Lesley E Northrop; Christopher M Luccarelli; Ali B Naini; Diane B Re; Michio Hirano; Hiroshi Mitsumoto
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-05-09       Impact factor: 4.092

Review 6.  Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.

Authors:  Vittoria Pagliarini; Piergiorgio La Rosa; Claudio Sette
Journal:  Hum Genet       Date:  2017-04-22       Impact factor: 4.132

7.  Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants.

Authors:  Stefan Reber; Jolanda Stettler; Giuseppe Filosa; Martino Colombo; Daniel Jutzi; Silvia C Lenzken; Christoph Schweingruber; Rémy Bruggmann; Angela Bachi; Silvia Ml Barabino; Oliver Mühlemann; Marc-David Ruepp
Journal:  EMBO J       Date:  2016-06-01       Impact factor: 11.598

Review 8.  Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis.

Authors:  Shuo-Chien Ling; Magdalini Polymenidou; Don W Cleveland
Journal:  Neuron       Date:  2013-08-07       Impact factor: 17.173

9.  Minor snRNA gene delivery improves the loss of proprioceptive synapses on SMA motor neurons.

Authors:  Erkan Y Osman; Meaghan Van Alstyne; Pei-Fen Yen; Francesco Lotti; Zhihua Feng; Karen Ky Ling; Chien-Ping Ko; Livio Pellizzoni; Christian L Lorson
Journal:  JCI Insight       Date:  2020-06-18

Review 10.  Alternative Splicing of ALS Genes: Misregulation and Potential Therapies.

Authors:  Benedetta Perrone; Valentina La Cognata; Teresa Sprovieri; Carmine Ungaro; Francesca Luisa Conforti; Sebastiano Andò; Sebastiano Cavallaro
Journal:  Cell Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.